Disease Info Card

Enteropathy-associated T-cell Lymphoma

Information about Enteropathy-associated T-cell Lymphoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Enteropathy-associated T-cell Lymphoma

Most recent studies have shown that Enteropathy-associated T-cell Lymphoma shares some biological mechanisms with abdominal-pain, atrophy, b-cell-lymphomas, celiac-disease, diarrhea, diffuse-large-b-cell-lymphoma, intestinal-diseases, intestinal-neoplasms, intestinal-perforation, ki-1--anaplastic-large-cell-lymphoma, lymphoma, lymphoma-non-hodgkin, malabsorption-syndrome, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasms, pain, peripheral-t-cell-lymphoma, t-cell-lymphoma, ulcer.

Among the many pathways, these few ones have gauged particular interests from scientists studying Enteropathy-associated T-cell Lymphoma, and have been seen in publications frequently: Adaptive Immune Response, Cell Cycle, Cell Differentiation, Cell Proliferation, Coagulation, Dna Amplification, Dna Repair, Excretion, Histone Deacetylation, Humoral Immune Response, Immune Response, Localization, Menopause, Mismatch Repair, Natural Killer Cell Differentiation, Nodulation, Pathogenesis, Regeneration, Reverse Transcription, T Cell Proliferation

Quite a number of genes have been found to play important roles in Enteropathy-associated T-cell Lymphoma, such as ALK, CD4, CD5, CD8A, CDKN2A, CTLA4, DDIT3, GNAI1, GZMB, HLA-DQA1, ITGAE, KRT20, MID1, MME, MS4A1, NCAM1, NOD2, TIA1, TNFRSF8. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.